Penyakit tidak menular (PTM) diprediksi akan meningkat. Di Indonesia, PTM mengalami baik peningkatan maupun penurunan. Adanya perbedaan antara prediksi dengan data dapat dikarenakan terbatasnya data terpublikasi sehingga kurang menggambarkan perkembangan terkini PTM. Untuk mengetahui lebih jauh mengenai perkembangan PTM di Indonesia, dibutuhkan data prevalensi PTM pada daerah tertentu, terutama di Kota Bandung. Tujuan penelitian yaitu mengetahui prevalensi PTM di Kota Bandung dan perkembangannya. Penelitian ini merupakan penelitian deskriptif observasional dengan desain studi potong lintang. Objek penelitian berupa laporan bulanan 1 (LB1) Sistem Pencatatan dan Pelaporan Puskesmas (SP3) Kota Bandung tahun 2013, 2014, dan 2015. Penelitian dilakukan di Kota Bandung pada Bulan Februari 2016-November 2016. Hasil menunjukan bahwa prevalensi PTM di Kota Bandung pada tahun 2013, 2014, dan 2015 secara berurutan yaitu 25,35%, 23,21%, dan 26,98%. Kategori PTM yang meningkat diantaranya penyakit kelainan metabolik. Disimpulkan bahwa telah terjadi peningkatan prevalensi PTM di Kota Bandung dari tahun 2013 ke tahun 2015. Di masa mendatang, diperlukan data prevalensi PTM secara lebih menyeluruh dalam jangka waktu yang lebih lama untuk hasil yang lebih akurat.Kata kunci: Bandung, fasilitas kesehatan tingkat pertama, penyakit tidak menular, prevalensi

Thromboembolic events are potentially life-threatening clinical complications found in β-thalassemia patients. The pathogenesis of the hypercoagulable state in β-thalassemia patients results from the degradation of excess α-globin chains in red blood cells, leading to intracellular labile iron accumulation, oxidative stress, and more rigid, deformed, and eventually prematurely damaged red blood cells. This process is associated with the loss of the normal asymmetrical distribution of membrane phosphatidylserine and its exposure to the outer surface of the blood cell membrane resulting in the formation of tenase complexes, prothrombinase, and thrombin complexes. Increased thrombins lead to platelet activation and platelet-derived microparticles synthesis, which in turn contributes to thrombus formation. This study aimed to determine the increase in the platelet-derived microparticle count by direct labeling of CD62P and CD41 monoclonal antibodies in β-thalassemia patients when compared with normal subjects. This was a cross-sectional analytical quantitative study conducted in Dr.

Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe anemia and thus regular blood transfusion is necessary. However, there have been known transfusions-related consequences, including iron overload and multi-organ damage. The aims of this study were to evaluate liver and cardiac function in youth and adult transfusion-dependent Indonesian thalassemic patients and to assess its correlation with serum ferritin levels, as well as T2 ∗ magnetic resonance imaging (MRI). Transfusion-dependent thalassemic (TDT) outpatients (n = 66; mean age, 21.5 ± 7.2 years) were carried out for the complete assessment consisting of blood test including liver enzyme and serum ferritin, followed by electrocardiography (ECG) and echocardiography. Subjects were also divided by serum ferritin levels into three groups: < 2500 ng/mL, 2500–5000 ng/mL, and >5000 ng/mL. Additionally, subgroup analysis in patients with T2∗ MRI assessment was conducted. In terms of age of first blood transfusion, subjects with ferritin >5000 ng/mL were the youngest among others. The alanine aminotransferase (ALT) levels in group with serum ferritin >5000 ng/mL were significantly higher than those of the group with serum ferritin <2500 ng/mL. Additionally, youth and adult TDT patients whose serum ferritin >5000 ng/mL had significantly lower tricuspid annular plane systolic excursion (TAPSE) when compared with those who had serum ferritin <2500 ng/mL. Similarly, TAPSE in patients with moderate cardiac siderosis based on cardiac T2∗ MRI was significantly lower than those without cardiac siderosis. There was significant, but only moderate correlation between serum ferritin and cardiac T2∗ MRI. Based on these findings, it is important to routinely monitor iron accumulation-related complications, including liver and cardiac damage in youth and adult TDT patients.

Background. Patients with thalassemia major may suffer from complications due to iron overload. It has been suggested that several adipokines may play a potential role in the development of complications in thalassemia. Fatty acid-binding protein 4 (FABP4) is one of the adipokines, bridging several aspects of metabolic and inflammatory pathways. Little is known about the relationship between this adipokine and cardiac and liver function, especially in patients with thalassemia major. Aims. This study is aimed at determining serum FABP4 levels in patients with thalassemia major and whether its concentration correlated with serum ferritin levels, as well as cardiac and liver function. Methods. Thalassemia major outpatients ( n = 48 ) completed laboratory examination, echocardiography, and electrocardiography. Results. The mean age was 21.9 ± 8.0 years. A negative and weak correlation between serum ferritin and FABP4 was observed ( r = − 0.291 , p < 0.05 ). In addition, there was moderate and positive correlation between left atrial volume index (LAVI) and FABP4 ( r = 0.316 , p < 0.05 ). Conclusions. Serum FABP4 correlated with serum ferritin and cardiac function in patients with thalassemia major. FABP4 may be a potential clinical biomarker for cardiac dysfunction via metabolic and inflammatory pathways due to iron accumulation and toxicity in patients with thalassemia major.